1. Home
  2. DARE vs QCLS Comparison

DARE vs QCLS Comparison

Compare DARE & QCLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$2.08

Market Cap

33.4M

Sector

Health Care

ML Signal

HOLD

QCLS

Q/C Technologies Inc.

HOLD

Current Price

$3.85

Market Cap

31.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DARE
QCLS
Founded
2015
2014
Country
United States
United States
Employees
N/A
2
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.4M
31.1M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
DARE
QCLS
Price
$2.08
$3.85
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
147.6K
256.7K
Earning Date
05-14-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,807,885.00
N/A
Revenue This Year
$2,115.12
N/A
Revenue Next Year
$122.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$2.50
52 Week High
$9.19
$8.17

Technical Indicators

Market Signals
Indicator
DARE
QCLS
Relative Strength Index (RSI) 48.74 49.33
Support Level $1.95 $3.47
Resistance Level $2.23 $3.86
Average True Range (ATR) 0.13 0.29
MACD 0.02 0.01
Stochastic Oscillator 54.17 45.21

Price Performance

Historical Comparison
DARE
QCLS

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About QCLS Q/C Technologies Inc.

Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.

Share on Social Networks: